A National Standard for Toxicology Reimbursements?

During the week of July 20th, the Centers for Medicare and Medicaid Services (CMS) held a hearing to address reimbursement policies for various lab services, including urine drug testing.

According to Andrea G. Barthwell, MD, FASAM, who manages Two Dreams Treatment Centers and is a consultant to the laboratory industry, Palmetto, a CMS claims processing contractor overseeing one of the 10 CMS jurisdictions, has adopted a new urine-testing reimbursement model for its region, which she predicts will ultimately become the nationwide standard. The model does not allow for additional reimbursement when an immunoassay test at a lab is used to confirm a test from the point of care.

Read more about it here: http://www.addictionpro.com/article/urine-drug-testing-model-likely-roll-out-nationwide

About Jeffrey Lynne

Jeffrey C. Lynne is a South Florida native, representing individuals and business entities relating to licensing, accreditation, regulatory compliance, business structure, marketing, real estate, zoning and litigation pertaining to substance abuse treatment facilities and sober living residences. Mr. Lynne has been recognized across the region as a leader in progressive public dialogue about the role that substance abuse treatment has within our communities and the fundamental need and right to provide safe and affordable housing for those who are both in treatment for addiction and alcoholism as well as those who are established in their recovery.

Comments